Relay Therapeutics prices $300M public offering of 11.32M shares at $26.50 per share

Relay Therapeutics, Inc.

Priced public offering of 11,320,755 shares at $26.50/share; gross proceeds ~$300M.
Net proceeds expected ~$284.5M after underwriting discounts and expenses.
Underwriters granted 30-day option to buy up to 1,698,113 additional shares.
Offering expected to close on September 15, 2022; Goldman Sachs, J.P. Morgan, Cowen, BofA act as managers.
All shares sold by Relay Therapeutics; shelf registration effective.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.